Soc. Generale Call 46 COP 20.09.2.../ DE000SW23CB7 /
10/06/2024 21:35:18 | Chg.0.000 | Bid10/06/2024 | Demandez à10/06/2024 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Bid taille: 10,000 |
0.020 Ask la taille: 10,000 |
COMPUGROUP MED. NA O... | 46.00 - | 20/09/2024 | Call |
GlobeNewswire
00:24
ROSEN, LEADING INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Inquire About Securities...
GlobeNewswire
00:19
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Perion Network Ltd. Inv...
GlobeNewswire
00:15
Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
GlobeNewswire
00:13
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before...
GlobeNewswire
00:00
GICAI launches revolutionary global digital currency quantitative trading platform to improve invest...
GlobeNewswire
10/06
Empower Healthcare Solutions and DispatchHealth® collaborate to bring in-home urgent medical care to...
GlobeNewswire
10/06
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primar...
GlobeNewswire
10/06
Atour Lifestyle Holdings Limited Announces Proposed Registered Secondary Offering of American Deposi...
GlobeNewswire
10/06
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hertz Global Holdings, Inc. Investors to Secure Counsel B...
GlobeNewswire
10/06
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
10/06
Bitfarms Announces Toronto Stock Exchange Deferral of Consideration of Shareholder Rights Plan
GlobeNewswire
10/06
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to...
GlobeNewswire
10/06
Inception Growth Acquisition Limited Announces Extension of Business Combination Period and Addition...
GlobeNewswire
10/06
CANON UNVEILS THE FUTURE OF EVERYDAY VR CONTENT CREATION WITH NEW DUAL FISHEYE LENS
GlobeNewswire
10/06
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primar...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page